Manabu Soda

15.1k total citations · 5 hit papers
47 papers, 10.5k citations indexed

About

Manabu Soda is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Manabu Soda has authored 47 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Manabu Soda's work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (17 papers) and Cancer Genomics and Diagnostics (10 papers). Manabu Soda is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (17 papers) and Cancer Genomics and Diagnostics (10 papers). Manabu Soda collaborates with scholars based in Japan, United Kingdom and United States. Manabu Soda's co-authors include Hiroyuki Mano, Young Lim Choi, Yuichi Ishikawa, Yoshihiro Yamashita, Shuji Takada, Kengo Takeuchi, Munehiro Enomoto, Yukihiko Sugiyama, Hisashi Hatanaka and Toshiro Niki and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Manabu Soda

46 papers receiving 10.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

2007 4.0k citations Manabu Soda, Young Lim Choi et al. Nature profile →
RET, ROS1 and ALK fusions in lung cancer

2012 963 citations Kengo Takeuchi, Manabu Soda et al. profile →
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

2010 915 citations Young Lim Choi, Manabu Soda et al. New England Journal of Medicine profile →
Oncogenic mutations of ALK kinase in neuroblastoma

2008 640 citations Young Lim Choi, Manabu Soda et al. Nature profile →
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

2009 557 citations Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research profile →

Peers

Manabu Soda

PRM

ONCOL

PFM

Young Lim Choi Japan

Hidefumi Sasaki Japan

Koji Tsuta Japan

Yoon‐La Choi South Korea

Lukas C. Amler United States

Takayuki Kosaka Japan

Juliann Chmielecki United States

Jeffrey C. Lee United States

J. Guillermo Paez United States

Aurélien de Reyniès France

Young Lim Choi Japan

Manabu Soda

6.8k ×0.9

PRM

5.7k ×1.0

ONCOL

5.0k ×1.1

2.9k ×1.0

1.3k ×1.0

PFM

Citations per year, relative to Manabu Soda Manabu Soda (= 1×) peers Young Lim Choi

Countries citing papers authored by Manabu Soda

Since Specialization

Citations

This map shows the geographic impact of Manabu Soda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manabu Soda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manabu Soda more than expected).

Fields of papers citing papers by Manabu Soda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manabu Soda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manabu Soda. The network helps show where Manabu Soda may publish in the future.

Co-authorship network of co-authors of Manabu Soda

This figure shows the co-authorship network connecting the top 25 collaborators of Manabu Soda. A scholar is included among the top collaborators of Manabu Soda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manabu Soda. Manabu Soda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sato, Kazuhito, Masahito Kawazu, Yoko Yamamoto, et al.. (2018). Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability–High Colorectal Cancers. Clinical Cancer Research. 25(1). 378–389. 44 indexed citations

Hashizume, Osamu, Takayuki Mito, Akinori Shimizu, et al.. (2015). Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects. Scientific Reports. 5(1). 10434–10434. 65 indexed citations

Ando, Mizuo, Masahito Kawazu, Toshihide Ueno, et al.. (2013). Cancer‐associated missense mutations of caspase‐8 activate nuclear factor‐κB signaling. Cancer Science. 104(8). 1002–1008. 34 indexed citations

Yamada, Tadaaki, Shinji Takeuchi, Junya Nakade, et al.. (2012). Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells. Clinical Cancer Research. 18(13). 3592–3602. 93 indexed citations

Soda, Manabu, Kazutoshi Isobe, Akira Inoue, et al.. (2012). A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(20). 5682–5689. 96 indexed citations

Togashi, Yuki, Manabu Soda, Seiji Sakata, et al.. (2012). KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only. PLoS ONE. 7(2). e31323–e31323. 205 indexed citations

Takeuchi, Kengo, Manabu Soda, Yuki Togashi, et al.. (2011). Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1–ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification. Clinical Cancer Research. 17(10). 3341–3348. 77 indexed citations

Ueno, Toshihide, Yoshihiro Yamashita, Manabu Soda, et al.. (2011). High‐throughput resequencing of target‐captured cDNA in cancer cells. Cancer Science. 103(1). 131–135. 14 indexed citations

Sakairi, Yuichi, Takahiro Nakajima, Kazuhiro Yasufuku, et al.. (2010). EML4-ALK Fusion Gene Assessment Using Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. Clinical Cancer Research. 16(20). 4938–4945. 125 indexed citations

10.

Choi, Young Lim, Manabu Soda, Yoshihiro Yamashita, et al.. (2010). EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors. New England Journal of Medicine. 363(18). 1734–1739. 915 indexed citations breakdown →

11.

Takeuchi, Kengo, Young Lim Choi, Yuki Togashi, et al.. (2009). KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer. Clinical Cancer Research. 15(9). 3143–3149. 557 indexed citations breakdown →

12.

Hatanaka, Hisashi, Shuji Takada, Kentaro Kurashina, et al.. (2009). Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening. Cancer Science. 101(1). 54–59. 32 indexed citations

13.

Choi, Young Lim, Kengo Takeuchi, Manabu Soda, et al.. (2008). Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer. Cancer Research. 68(13). 4971–4976. 346 indexed citations

14.

Soda, Manabu, Shuji Takada, Kengo Takeuchi, et al.. (2008). A mouse model for EML4-ALK -positive lung cancer. Proceedings of the National Academy of Sciences. 105(50). 19893–19897. 396 indexed citations

15.

Takeuchi, Kengo, Young Lim Choi, Manabu Soda, et al.. (2008). Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts. Clinical Cancer Research. 14(20). 6618–6624. 397 indexed citations

16.

Inamura, Kentaro, Kengo Takeuchi, Yuki Togashi, et al.. (2008). EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers. Journal of Thoracic Oncology. 3(1). 13–17. 374 indexed citations

17.

Tajima, Shunji, Manabu Soda, Masashi Bando, et al.. (2008). Preventive effects of edaravone, a free radical scavenger, on lipopolysaccharide‐induced lung injury in mice. Respirology. 13(5). 646–653. 25 indexed citations

18.

Soda, Manabu, Young Lim Choi, Munehiro Enomoto, et al.. (2007). Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature. 448(7153). 561–566. 4018 indexed citations breakdown →

19.

Choi, Young Lim, Ruri Kaneda, Tomoaki Wada, et al.. (2006). Identification of a constitutively active mutant of JAK3 by retroviral expression screening. Leukemia Research. 31(2). 203–209. 18 indexed citations

20.

Usui, Kazuhiro, et al.. (2004). [Electronic clinical pathway for community acquired pneumonia (e-CP CAP)].. PubMed. 42(7). 620–4. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact